| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1046328068 |
| P356 | DOI | 10.1038/SJ.ONC.1206152 |
| P8608 | Fatcat ID | release_b7ofgrjwmfbedpyofsj355yiyq |
| P698 | PubMed publication ID | 12555064 |
| P5875 | ResearchGate publication ID | 10928334 |
| P2093 | author name string | Olivier Albagli-Curiel | |
| P2860 | cites work | Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication foci | Q22010549 |
| The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma | Q24292242 | ||
| A putative silencer element in the IL-5 gene recognized by Bcl6 | Q24300928 | ||
| p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3 | Q24313244 | ||
| BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor | Q24522565 | ||
| The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis | Q24531167 | ||
| Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell proto-oncogene product | Q24554237 | ||
| Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma | Q24561494 | ||
| Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia | Q24597732 | ||
| Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4 | Q24671741 | ||
| Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 | ||
| Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1 | Q28139194 | ||
| Two critical hits for promyelocytic leukemia | Q28139515 | ||
| Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53 | Q28143652 | ||
| Stage-specific modulation of IFN-regulatory factor 4 function by Krüppel-type zinc finger proteins | Q28187914 | ||
| Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF | Q28200033 | ||
| Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas | Q28207345 | ||
| Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene | Q28217075 | ||
| LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas | Q28255448 | ||
| Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma | Q28256118 | ||
| Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase | Q28284593 | ||
| Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene | Q28295956 | ||
| Disruption of the Bcl6 gene results in an impaired germinal center formation | Q28509600 | ||
| The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation | Q28584806 | ||
| Control of inflammation, cytokine expression, and germinal center formation by BCL-6 | Q28585541 | ||
| The proto-oncogene Bc16 inhibits apoptotic cell death in differentiation-induced mouse myogenic cells | Q28589662 | ||
| The Bcl-2 protein family: arbiters of cell survival | Q29618158 | ||
| APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity | Q29977757 | ||
| A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling | Q30828170 | ||
| DNA replication progresses on the periphery of nuclear aggregates formed by the BCL6 transcription factor | Q30949530 | ||
| Co-localization of Polycomb protein and GAGA factor on regulatory elements responsible for the maintenance of homeotic gene expression | Q33886885 | ||
| Structure of a polycomb response element and in vitro binding of polycomb group complexes containing GAGA factor | Q33963254 | ||
| Cellular senescence: mitotic clock or culture shock? | Q34019131 | ||
| Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. | Q34324111 | ||
| McBindall--a better name for CCAAT/enhancer binding proteins? | Q34432691 | ||
| Regulation of gene expression by the proto-oncogene BCL-6. | Q34498083 | ||
| The disparity between human cell senescence in vitro and lifelong replication in vivo | Q34713118 | ||
| Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor | Q35203930 | ||
| A short mutational hot spot in the first intron of BCL-6 is associated with increased BCL-6 expression and with longer overall survival in large B-cell lymphomas | Q35788912 | ||
| The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation. | Q36248087 | ||
| BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci | Q36322298 | ||
| Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein | Q36594782 | ||
| BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor | Q37477121 | ||
| Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. | Q37626496 | ||
| The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis | Q39576033 | ||
| The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. | Q39725251 | ||
| Target genes downregulated by the BCL-6/LAZ3 oncoprotein in mouse Ba/F3 cells | Q40807668 | ||
| Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. | Q40836930 | ||
| Nonrandom 4p13 rearrangements of the RhoH/TTF gene, encoding a GTP-binding protein, in non-Hodgkin's lymphoma and multiple myeloma | Q40881085 | ||
| Adenovirus-mediated high expression of BCL-6 in CV-1 cells induces apoptotic cell death accompanied by down-regulation of BCL-2 and BCL-X(L). | Q40976625 | ||
| Targeting the PML/RAR alpha translocation product triggers apoptosis in promyelocytic leukemia cells | Q41002148 | ||
| Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation | Q41127074 | ||
| Significance of rearrangement of the BCL6 gene in B-cell lymphoid neoplasms | Q41646099 | ||
| Photoreceptor development: breaking down the barriers. | Q41690548 | ||
| The GAGA factor of Drosophila interacts with SAP18, a Sin3-associated polypeptide | Q42055789 | ||
| The BCL6 gene is predominantly expressed in keratinocytes at their terminal differentiation stage | Q42526807 | ||
| A new functional domain of Bcl6 family that recruits histone deacetylases | Q42824972 | ||
| Dual functions of largest NURF subunit NURF301 in nucleosome sliding and transcription factor interactions | Q47070476 | ||
| Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes | Q47982616 | ||
| Increased expression of the LAZ3 (BCL6) proto-oncogene accompanies murine skeletal myogenesis. | Q51092260 | ||
| Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome. | Q52171298 | ||
| The role of Bcl6 in mature cardiac myocytes. | Q52173615 | ||
| Purification and properties of an ATP-dependent nucleosome remodeling factor. | Q52546410 | ||
| Splicing factor SRP20 is a novel partner of BCL6 in a t(3;6)(q27;p21) translocation in transformed follicular lymphoma. | Q53395426 | ||
| Identification of negative regulatory regions within the first exon and intron of the BCL6 gene. | Q53404877 | ||
| BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. | Q55034216 | ||
| B Cell Receptor Engagement and T Cell Contact Induce bcl-6 Somatic Hypermutation in Human B Cells: Identity with Ig Hypermutation | Q58493959 | ||
| Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5'-RACE and LA - PCR analyses of biopsy samples | Q73359146 | ||
| Regulation of BCL-6 gene expression in human myeloid/monocytoid leukemic cells | Q73407905 | ||
| BCL-6 is phosphorylated at multiple sites in its serine- and proline-clustered region by mitogen-activated protein kinase (MAPK) in vivo | Q73428258 | ||
| BCL-6 regulates chemokine gene transcription in macrophages | Q74268408 | ||
| The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene | Q77491941 | ||
| Immunoglobulin (Ig)/BCL6 versus non-Ig/BCL6 gene fusion in diffuse large B-cell lymphoma corresponds to a high- versus low-level expression of BCL6 mRNA | Q77854105 | ||
| Molecular pathogenesis of B cell malignancy: the role of BCL-6 | Q77968706 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 507-516 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Ambivalent role of BCL6 in cell survival and transformation | |
| P478 | volume | 22 |
| Q25257330 | A new description of cellular quiescence |
| Q92424125 | Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma |
| Q39684544 | BCL6 canalizes Notch-dependent transcription, excluding Mastermind-like1 from selected target genes during left-right patterning |
| Q39975326 | BCL6-mediated attenuation of DNA damage sensing triggers growth arrest and senescence through a p53-dependent pathway in a cell context-dependent manner. |
| Q37078872 | Bcl6a function is required during optic cup formation to prevent p53-dependent apoptosis and colobomata |
| Q36544129 | Characterization of adipose-derived stem cells from subcutaneous and visceral adipose tissues and their function in breast cancer cells |
| Q90358222 | Characterizing Atypical BCL6 Signal Patterns Detected by Digital Fluorescence In Situ Hybridization (FISH) Analysis |
| Q35426799 | Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction |
| Q36007623 | EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts |
| Q24301062 | Expression and clinical role of the bric-a-brac tramtrack broad complex/poxvirus and zinc protein NAC-1 in ovarian carcinoma effusions |
| Q33914049 | Homoharringtonine suppresses imatinib resistance via the Bcl-6/p53 pathway in chronic myeloid leukemia cell lines |
| Q34353406 | Insights into gene expression changes impacting B-cell transformation: cross-species microarray analysis of bovine leukemia virus tax-responsive genes in ovine B cells |
| Q27642845 | Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain |
| Q33316851 | Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFkappaB transcription factors |
| Q58762852 | STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells |
| Q24812693 | Sequence and structural analysis of BTB domain proteins |
| Q52085890 | Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. |
| Q39772359 | The FoxO/Bcl-6/cyclin D2 pathway mediates metabolic and growth factor stimulation of proliferation in Min6 pancreatic beta-cells |
| Q50564001 | The proto-oncogene BCL6 promotes survival of olfactory sensory neurons. |
| Q34598347 | The pupal specifier broad directs progressive morphogenesis in a direct-developing insect |
| Q38345700 | Transcriptional repressor BCL-6 immortalizes germinal center-like B cells in the absence of p53 function |
| Q64086763 | Unraveling Tumor Heterogeneity in an Apparently Monolithic Disease: BCL2 and Other Players in the Genetic Landscape of Nodal Follicular Lymphoma |
| Q28576766 | ZENON, a novel POZ Kruppel-like DNA binding protein associated with differentiation and/or survival of late postmitotic neurons |
| Q38992318 | Zinc finger and BTB domain-containing protein 3 is essential for the growth of cancer cells |
| Q36471327 | miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model |
Search more.